Zhejiang Yatai Pharmaceutical Co Ltd
SZSE:002370
Zhejiang Yatai Pharmaceutical Co Ltd
SZSE:002370
Price:
6.93
CNY
-1.7%
Market Closed
Market Cap:
¥5.2B
Balance Sheet
Balance Sheet Decomposition
Zhejiang Yatai Pharmaceutical Co Ltd
Zhejiang Yatai Pharmaceutical Co Ltd
Balance Sheet Decomposition is not available for
Zhejiang Yatai Pharmaceutical Co Ltd
Zhejiang Yatai Pharmaceutical Co Ltd
Balance Sheet
Zhejiang Yatai Pharmaceutical Co Ltd
Zhejiang Yatai Pharmaceutical Co Ltd
Currency: CNY
| Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Cash & Cash Equivalents |
68
|
33
|
67
|
390
|
367
|
264
|
270
|
225
|
461
|
814
|
767
|
535
|
1 179
|
903
|
801
|
722
|
720
|
720
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
801
|
722
|
720
|
720
|
|
| Cash Equivalents |
68
|
33
|
67
|
390
|
367
|
264
|
270
|
225
|
461
|
814
|
767
|
535
|
1 179
|
903
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
72
|
128
|
123
|
131
|
138
|
136
|
131
|
172
|
262
|
331
|
335
|
474
|
131
|
305
|
111
|
148
|
141
|
138
|
|
| Accounts Receivables |
42
|
54
|
62
|
81
|
85
|
96
|
75
|
85
|
160
|
273
|
274
|
398
|
73
|
118
|
70
|
89
|
80
|
95
|
|
| Other Receivables |
30
|
74
|
61
|
51
|
53
|
40
|
56
|
87
|
103
|
58
|
61
|
76
|
58
|
187
|
41
|
59
|
61
|
43
|
|
| Inventory |
50
|
66
|
56
|
81
|
85
|
102
|
89
|
96
|
117
|
79
|
115
|
171
|
155
|
65
|
61
|
95
|
89
|
70
|
|
| Other Current Assets |
5
|
3
|
3
|
7
|
5
|
2
|
2
|
1
|
12
|
26
|
48
|
68
|
17
|
2
|
23
|
19
|
4
|
27
|
|
| Total Current Assets |
195
|
230
|
249
|
610
|
594
|
504
|
492
|
494
|
852
|
1 250
|
1 265
|
1 247
|
1 482
|
1 275
|
996
|
1 005
|
955
|
955
|
|
| PP&E Net |
138
|
152
|
164
|
227
|
250
|
264
|
260
|
291
|
298
|
341
|
597
|
846
|
596
|
488
|
434
|
386
|
365
|
338
|
|
| PP&E Gross |
0
|
152
|
164
|
227
|
250
|
264
|
260
|
291
|
298
|
341
|
597
|
846
|
596
|
488
|
434
|
386
|
365
|
338
|
|
| Accumulated Depreciation |
0
|
57
|
70
|
86
|
103
|
123
|
146
|
159
|
191
|
222
|
247
|
279
|
632
|
496
|
560
|
296
|
628
|
660
|
|
| Intangible Assets |
26
|
24
|
24
|
23
|
23
|
22
|
21
|
47
|
84
|
88
|
87
|
201
|
103
|
113
|
119
|
77
|
70
|
70
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
16
|
16
|
10
|
677
|
670
|
670
|
670
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
4
|
3
|
4
|
4
|
4
|
5
|
5
|
6
|
19
|
26
|
35
|
34
|
80
|
75
|
58
|
53
|
38
|
38
|
|
| Other Long-Term Assets |
1
|
1
|
1
|
1
|
1
|
8
|
7
|
2
|
131
|
95
|
85
|
299
|
8
|
6
|
4
|
3
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
16
|
16
|
10
|
677
|
670
|
670
|
670
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
362
N/A
|
410
+13%
|
442
+8%
|
865
+96%
|
872
+1%
|
818
-6%
|
802
-2%
|
849
+6%
|
2 061
+143%
|
2 471
+20%
|
2 738
+11%
|
3 297
+20%
|
2 268
-31%
|
1 956
-14%
|
1 611
-18%
|
1 524
-5%
|
1 429
-6%
|
1 402
-2%
|
|
| Liabilities | |||||||||||||||||||
| Accounts Payable |
44
|
67
|
54
|
58
|
55
|
51
|
46
|
44
|
273
|
163
|
109
|
85
|
44
|
45
|
54
|
90
|
52
|
46
|
|
| Accrued Liabilities |
6
|
5
|
7
|
7
|
7
|
11
|
12
|
10
|
12
|
16
|
14
|
27
|
21
|
26
|
22
|
23
|
17
|
17
|
|
| Short-Term Debt |
143
|
78
|
119
|
82
|
58
|
50
|
30
|
39
|
309
|
0
|
72
|
95
|
3
|
0
|
0
|
50
|
50
|
30
|
|
| Current Portion of Long-Term Debt |
0
|
30
|
24
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
24
|
65
|
84
|
112
|
2
|
0
|
302
|
|
| Other Current Liabilities |
12
|
7
|
7
|
1
|
7
|
2
|
4
|
7
|
158
|
95
|
72
|
59
|
40
|
137
|
27
|
58
|
43
|
22
|
|
| Total Current Liabilities |
205
|
187
|
212
|
145
|
126
|
114
|
92
|
100
|
753
|
274
|
268
|
289
|
173
|
292
|
214
|
222
|
162
|
416
|
|
| Long-Term Debt |
0
|
24
|
0
|
0
|
0
|
0
|
0
|
0
|
513
|
0
|
0
|
165
|
982
|
930
|
863
|
900
|
639
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
3
|
3
|
6
|
4
|
4
|
4
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
9
|
10
|
12
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
101
|
319
|
477
|
71
|
95
|
97
|
44
|
9
|
|
| Total Liabilities |
205
N/A
|
211
+3%
|
212
+1%
|
145
-32%
|
127
-13%
|
114
-10%
|
92
-19%
|
101
+10%
|
1 275
+1 160%
|
285
-78%
|
379
+33%
|
785
+107%
|
1 635
+108%
|
1 296
-21%
|
1 178
-9%
|
1 223
+4%
|
848
-31%
|
430
-49%
|
|
| Equity | |||||||||||||||||||
| Common Stock |
90
|
90
|
90
|
120
|
204
|
204
|
204
|
204
|
204
|
268
|
537
|
537
|
537
|
537
|
537
|
537
|
609
|
729
|
|
| Retained Earnings |
59
|
100
|
130
|
172
|
198
|
156
|
162
|
198
|
233
|
338
|
513
|
668
|
1 415
|
1 388
|
1 616
|
1 749
|
1 761
|
1 727
|
|
| Additional Paid In Capital |
9
|
9
|
10
|
428
|
343
|
344
|
344
|
342
|
342
|
1 575
|
1 307
|
1 307
|
1 307
|
1 308
|
1 309
|
1 310
|
1 594
|
1 907
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
6
|
4
|
2
|
1
|
205
|
204
|
204
|
204
|
139
|
63
|
|
| Total Equity |
158
N/A
|
199
+26%
|
230
+16%
|
720
+213%
|
745
+4%
|
704
-6%
|
710
+1%
|
747
+5%
|
786
+5%
|
2 186
+178%
|
2 359
+8%
|
2 512
+6%
|
633
-75%
|
660
+4%
|
433
-34%
|
301
-30%
|
581
+93%
|
972
+67%
|
|
| Total Liabilities & Equity |
362
N/A
|
410
+13%
|
442
+8%
|
865
+96%
|
872
+1%
|
818
-6%
|
802
-2%
|
849
+6%
|
2 061
+143%
|
2 471
+20%
|
2 738
+11%
|
3 297
+20%
|
2 268
-31%
|
1 956
-14%
|
1 611
-18%
|
1 524
-5%
|
1 429
-6%
|
1 402
-2%
|
|
| Shares Outstanding | |||||||||||||||||||
| Common Shares Outstanding |
306
|
306
|
306
|
408
|
408
|
408
|
408
|
408
|
408
|
537
|
537
|
537
|
537
|
537
|
537
|
537
|
609
|
729
|
|
Switch to:
Switch to:
See Also
Discover More
